About a dozen activists from the Extinction Rebellion climate group briefly occupied the entrance lobby of French bank BNP ...

The Danish drugmaker unveiled a series of initiatives to increase access to Wegovy and clamp down on use of the knock-off ...

Novo has a strong balance sheet and ended 2024 with about DKK 26 billion in cash and marketable securities and DKK 103 billion of debt (following the acquisition of Catalent manufacturing sites in ...

Act may protect citizens, but some experts in the life sciences industry are worried about the potential challenges it may ...

The company behind the weight loss sensation that transformed bodies and bank accounts across America just showed its own CEO ...

It was a ‘mutual agreement,’ Novo says in a statement. A search for Fruergaard Jørgensen’s successor is ongoing.

Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...

Eli Lilly (NYSE: LLY) was an unstoppable bet in the past few years, but LLY stock finally started plateauing in the latter ...

President Donald Trump's executive order mandates drugmakers to lower prices to match those in affluent nations, threatening ...

President Donald Trump’s latest bid to slash prescription drug prices has once again stirred heated debate about the high ...

US President Donald Trump said Monday he would slash drug prices so they match those abroad, accusing Europe in particular of ...

Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...